135 related articles for article (PubMed ID: 15613918)
1. Factor V inhibitors: rare or not so uncommon? A multi-laboratory investigation.
Favaloro EJ; Posen J; Ramakrishna R; Soltani S; McRae S; Just S; Aboud M; Low J; Gemmell R; Kershaw G; Coleman R; Dean M
Blood Coagul Fibrinolysis; 2004 Oct; 15(8):637-47. PubMed ID: 15613918
[TBL] [Abstract][Full Text] [Related]
2. An acquired factor V inhibitor associated with defective factor V function, storage and binding to multimerin 1.
Jeimy SB; Krakow EF; Fuller N; Tasneem S; Hayward CP
J Thromb Haemost; 2008 Feb; 6(2):395-7. PubMed ID: 18047547
[No Abstract] [Full Text] [Related]
3. [Acquired factor V deficiency: a rare bleeding disorder with variable clinical presentations].
Alcantara M; Ducastelle S; Rugeri L; Dargaud Y
Rev Med Interne; 2011 May; 32(5):e59-61. PubMed ID: 20638758
[TBL] [Abstract][Full Text] [Related]
4. Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: a case report and review of the literature.
Wang X; Qin X; Yu Y; Wang R; Liu X; Ji M; Zhou M; Chen C
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):334-341. PubMed ID: 27428013
[TBL] [Abstract][Full Text] [Related]
5. Acquired factor V inhibitor developing in a patient with esophageal squamous cell carcinoma.
Ahmadinejad M; Roushan N
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):97-9. PubMed ID: 23080366
[TBL] [Abstract][Full Text] [Related]
6. Acquired factor V inhibitor after exposure to topical human thrombin related to an otorhinolaryngological procedure.
Donohoe K; Levine R
J Thromb Haemost; 2015 Oct; 13(10):1787-9. PubMed ID: 26270511
[TBL] [Abstract][Full Text] [Related]
7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
8. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
[TBL] [Abstract][Full Text] [Related]
9. A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment.
Fujita Y; Nakazato T; Ito C; Masuda K; Osada Y; Aisa Y; Mori T
Ann Hematol; 2018 Oct; 97(10):2009-2010. PubMed ID: 29713749
[No Abstract] [Full Text] [Related]
10. Development of cephradine-induced acquired factor V inhibitors: a case report.
Wu MT; Pei SN
Ann Pharmacother; 2010 Oct; 44(10):1673-6. PubMed ID: 20807866
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience.
Sridharan M; Fylling KA; Ashrani AA; Chen D; Marshall AL; Hook CC; Cardel LK; Nichols WL; Pruthi RK
Thromb Res; 2018 Nov; 171():14-21. PubMed ID: 30227314
[TBL] [Abstract][Full Text] [Related]
12. Transfusion management of factor V deficiency: three case reports and review of the literature.
Gavva C; Yates SG; Rambally S; Sarode R
Transfusion; 2016 Jul; 56(7):1745-9. PubMed ID: 27125565
[TBL] [Abstract][Full Text] [Related]
13. Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin.
Tarantino MD; Ross MP; Daniels TM; Nichols WL
J Pediatr Hematol Oncol; 1997; 19(3):226-31. PubMed ID: 9201145
[TBL] [Abstract][Full Text] [Related]
14. Multimodality therapy of an acquired factor V inhibitor.
Fu YX; Kaufman R; Rudolph AE; Collum SE; Blinder MA
Am J Hematol; 1996 Apr; 51(4):315-8. PubMed ID: 8602633
[TBL] [Abstract][Full Text] [Related]
15. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency.
Cmolik BL; Spero JA; Magovern GJ; Clark RE
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):222-7; discussion 227-8. PubMed ID: 8429648
[TBL] [Abstract][Full Text] [Related]
16. Development of antibodies to bovine and human factor V in two children after exposure to topical bovine thrombin.
Israels SJ; Israels ED
Am J Pediatr Hematol Oncol; 1994 Aug; 16(3):249-54. PubMed ID: 8037345
[TBL] [Abstract][Full Text] [Related]
17. Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies.
Holme PA; Brosstad F; Tjønnfjord GE
Haemophilia; 2005 Sep; 11(5):510-5. PubMed ID: 16128896
[TBL] [Abstract][Full Text] [Related]
18. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation.
Favaloro EJ; Bonar R; Duncan E; Earl G; Low J; Aboud M; Just S; Sioufi J; Street A; Marsden K;
Thromb Haemost; 2006 Jul; 96(1):73-8. PubMed ID: 16807654
[TBL] [Abstract][Full Text] [Related]
19. [The antiphospholipid syndrome during chronic lymphatic leukemia. An association with anti-factor VIII antibodies].
Ghirarduzzi A; Silingardi M; D'Incà M; Tincani E
Ann Ital Med Int; 1999; 14(1):46-50. PubMed ID: 10528424
[TBL] [Abstract][Full Text] [Related]
20. Clinical and laboratory manifestations of anti-factor V antibodies.
Ortel TL
J Lab Clin Med; 1999 Apr; 133(4):326-34. PubMed ID: 10218762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
